Talking Euretina

Epizódok

• 
  Episode 84: Inside Euretina Innovation Spotlight: Retina, Industry & Regulators 21.07.2026 13p

  The Euretina Innovation Spotlight returns to Vienna on 30 September, bringing clinicians, industry, investors and regulators around one table. Prof. Anat Loewenstein, Prof. Nicole Eter and Dr. Kourous Rezaei tell Jonathan McCrea why innovation in retina is moving faster than ever, what the return of the EMA's Jane Mosley means for bridging Europe and the US, and why this exchange of ideas is something a traditional congress simply can't offer
• 
  Episode 83: Retinopathy of Prematurity: Has Anti-VEGF Changed the Game? 14.07.2026 31p

  Anti-VEGF has transformed how we treat retinopathy of prematurity — but at what long-term cost? Dr Kanmin Xue chairs a global discussion with Dr Domenico Lepore, Prof Wei-Chi Wu and Prof Andreas Stahl on injections versus laser, the RAINBOW and FIREFLEYE trial data, managing peripheral avascular retina, and why these babies may need follow-up for life. A frank look at the questions the evidence hasn't yet answered.
• 
  Episode 82: Uveal Melanoma in Pregnancy: To Treat or to Wait? 26.06.2026 16p

  A diagnosis of uveal melanoma during pregnancy forces an agonising question: treat now, or wait? Dr Emine Kiliç chairs a multidisciplinary discussion with Dr Iwona Rospond-Kubiak (Poznań), Prof. Antonia Joussen (Charité, Berlin) and radiation oncologist Dr Adam Chicheł on plaque brachytherapy and fetal radiation exposure, how gestational age shapes timing, and the reassuring — if limited — evidence on placental spread and maternal survival.
• 
  Episode 81: The Women in Retina survey - 5 years on 17.06.2026 21p

  Euretina will shortly relaunch the Women in Retina survey, building on the first dataset. In this podcast, Prof. Anat Loewenstein, Dr Federica Fossataro and Prof. Nicole Eter explore what has changed since the original 2021 study, what's new and why participation from the whole community - women and men alike - is essential to measuring real progress. The Women In Retina Initiative is sponsored by Bayer.
• 
  Episode 80: Geographic Atrophy: Rethinking Endpoints and Real-World Impact 02.05.2026 34p

  New therapies are reshaping geographic atrophy—but are trial endpoints keeping pace with clinical reality? Anat Loewenstein is joined by Sobha Sivaprasad and Kristina Pfau to examine how success in GA is measured, from lesion growth to functional vision. The panel explores microperimetry, contrast sensitivity, and emerging tools that may better reflect meaningful patient outcomes.
• 
  Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead 01.04.2026 35p

  A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific approaches
• 
  Episode 78: Insights from the EURETINA Mentorship Programme 16.03.2026 19p

  Three former mentees of the EURETINA Mentorship Programme share how the initiative helped shape their careers in retinal research and clinical practice. Özge Yanık Odabaş, Karolina Motloch and Omer Trivizki discuss mentorship, international collaboration, and the opportunities created through the programme’s growing alumni network. Their experiences highlight how structured mentorship can accelerate professional development for the next generation of retina specialists
• 
  Episode 77: Implementing AI in Retina Practice: From Screening to Decision Support 05.03.2026 37p

  Artificial intelligence is rapidly reshaping retina care — but where does it truly add value in daily practice? Professors Tien Wong and Daniel Ting join Stela Vujosevic to explore how AI is moving beyond screening into risk stratification, clinical decision support, and home monitoring. From infrastructure challenges to real-world implementation, this episode offers practical insights for retina specialists preparing for an AI-enabled future
• 
  Episode 76: AI in Diabetic Retinopathy: Screening, Biomarkers and What Comes Next 11.02.2026 30p

  Artificial intelligence is rapidly reshaping how we screen, classify, and treat diabetic retinal disease. Professor Aude Couturier, Professor Edoardo Midena, and Professor Reinier Schlingemann discuss real-world AI applications in diabetic retinopathy — from population screening and imaging biomarkers to phenotyping and precision treatment in diabetic macular oedema
• 
  Episode 75: Transitioning from Retina Specialist to Industry 19.01.2026 32p

  What drives leading retina specialists to trade the clinic for corporate innovation? In this episode, Euretina Board member Kourous Rezaei speaks with Jay Duker (CEO, Eyepoint), Sascha Fauser (SVP, Roche), and Marion Munk (CSO, Gutblick Group; CMO, Isarna Therapeutics) about their transitions from clinical practice to industry. Together they share insights on leadership, research, and the evolving relationship between academia and biotechnology in shaping the future of retinal therapeutics
• 
  Episode 74: Intuition in Uncharted Waters: The Art of Retinal Surgery 17.12.2025 39p

  In this episode Professors Dean Eliott, Grazia Pertile, and José García-Arumí join chair Kourous Rezaei to explore how surgical mastery is built through intuition, preparation, and reflection. They share practical insights on mentorship, focus, teamwork, and managing stressful cases — from avoiding coffee before surgery to resetting after complications — revealing that great surgeons are defined not just by skill, but by judgment, patience, and care for the patient
• 
  Episode 73: When to Treat Small Choroidal Melanomas: A Debate Between Early Intervention and Observation 09.12.2025 29p

  In this first-ever debate edition of Talking Euretina, Dr Rumana Hussain (Liverpool Ocular Oncology Centre) introduces Professors Arun Singh (Cole Eye Institute, Cleveland Clinic), Heinrich Heimann (Liverpool Ocular Oncology Service) and Bertil Damato (Moorfields Eye Hospital) as they debate one of ocular oncology’s most enduring questions — when to operate on small choroidal melanomas. The panel examines diagnostic uncertainty, genetic risk and patient choice in determining when to treat.
• 
  Episode 72: Bridging the Gap - Why Diversity in Retina Trials Can’t Wait 27.11.2025 42p

  Retinal diseases disproportionately affect certain populations—yet these groups are underrepresented in research. In this episode, Dr. Christiana Dinah chairs a global panel including Drs. Adrienne Scott, Charles Wykoff and Jeremiah Brown to explore the systemic and structural barriers to inclusion in retina trials, and why the stakes for equity have never been higher
• 
  Episode 71: Restoring Vision with Bionics: Inside the Prima Implant Breakthrough 10.11.2025 19p

  In this episode, Prof. Frank Holz leads a panel discussion on a major leap forward in retinal prosthesis: the Prima system for geographic atrophy. Joined by Dr. Mahi Muqit and Prof. Lars-Olof Hattenbach, they explore how their extraordinary wireless subretinal implant is restoring visual perception in late-stage AMD. 
• 
  Episode 70: Highlights from the Euretina Congress 2025 in Paris. 19.09.2025 24p

  In this episode, Profs. Lejla Vajzovic (USA), Sandrine Zweifel (Switzerland), and Heinrich Heimann (UK) reflect on a fantastic few days in Paris and share their highlights from the 2025 programme for you to watch back through the portal.
• 
  Episode 69: Pioneering Retina: Prof. Ursula Schmidt-Erfurth on AI, AMD & 25 Years of Euretina 31.08.2025 15p

  Euretina President Prof. Anat Loewenstein speaks with Prof. Ursula Schmidt-Erfurth, 25th Euretina Lecturer, about her groundbreaking career in retinal disease, from imaging innovations to AI-driven early detection. They discuss the EU-funded iScreen project, the future of AMD management, and the significance of two women presidents (past and present) as Euretina celebrates its 25th anniversary in Paris
• 
  Episode 68: AI, Epidemiology & Innovation: Prof. Korobelnik on the Future of Retina 28.08.2025 21p

  Ahead of his Gisbert Richard Lecture at this year’s Euretina Congress in Paris, Prof. Jean-François Korobelnik joins Prof. Nicole Eter to reflect on a career at the forefront of retinal research. From surgical breakthroughs to his leadership of the E3 consortium, and his cautious optimism for AI, Prof. Korobelnik shares insights on past progress and future priorities in retina
• 
  Episode 67: Throwing Away Wisdom – Maria Berrocal on Saving Proven Treatments for PDR and Retinal Detachment 15.08.2025 22p

  Ahead of her Kreissig Award Lecture at the Euretina Congress in Paris, Professor Maria Berrocal (Puerto Rico) joins Euretina past president Alistair Laidlaw to discuss why time-tested treatments like PRP and scleral buckling still matter. They explore the risks of over-reliance on anti-VEGF in proliferative diabetic retinopathy, the decline in buckle training, and how chandelier techniques could revive it
• 
  Episode 66: A Holistic Approach? Patient Experience, Mental Health and Emotional Intelligence 01.08.2025 33p

  In this thought-provoking episode, Professor Tariq Aslam and Retina International’s Avril Daly join Jonathan McCrea to explore the emotional and psychological dimensions of retinal disease. From the power of empathy in clinical care to the need for integrated mental health services, the discussion highlights why supporting patients beyond the medical chart is more vital than ever—especially in an AI-driven world.
• 
  Episode 65: Decoding White Spot Syndromes: Multimodal Imaging, Challenges & Clinical Clarity 15.07.2025 20p

  Ahead of her Ophthalmologica Lecture at this year’s Euretina Congress, Dr. Maria Vittoria Cicinelli joins Professor Bahram Bodaghi to explore the evolving understanding of white spot syndromes. From classic presentations of punctate inner choroidopathy (PIC) to emerging imaging insights and therapeutic uncertainties, the conversation highlights unmet needs, research gaps, and practical implications for clinicians managing posterior uveitis